Compounds > arginine

arginine and neurotensin (8-13)

arginine has been researched along with neurotensin (8-13) in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Büllesbach, EE; Dix, TA; Golden, PL; Lundquist, JT1
Dix, TA; Hadden, MK; Kokko, KP; Mazella, J; Orwig, KS1
Bernhardt, G; Biselli, S; Buschauer, A; Cabrele, C; Einsiedel, J; Gmeiner, P; Hübner, H; Keller, M; Kuhn, KK; Mollereau, C; Svobodová, J; Vanderheyden, PM; Wifling, D1

Other Studies

3 other study(ies) available for arginine and neurotensin (8-13)

ArticleYear
Topography of the neurotensin (NT)(8-9) binding site of human NT receptor-1 probed with NT(8-13) analogs.
    The journal of peptide research : official journal of the American Peptide Society, 2002, Volume: 59, Issue:2

    Topics: Amino Acid Substitution; Amino Acids; Animals; Arginine; Binding Sites; CHO Cells; Cricetinae; Humans; Kinetics; Neurotensin; Peptide Fragments; Radioligand Assay; Receptors, Neurotensin; Recombinant Proteins; Transfection

2002
Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues.
    Neuropharmacology, 2005, Volume: 49, Issue:8

    Topics: Animals; Antipsychotic Agents; Area Under Curve; Arginine; Biological Availability; Catalepsy; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Design; Haloperidol; Injections, Intraperitoneal; Lysine; Male; Motor Activity; Neurotensin; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin

2005
Mimicking of Arginine by Functionalized N(ω)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples.
    Journal of medicinal chemistry, 2016, Mar-10, Volume: 59, Issue:5

    Topics: Angiotensin II; Arginine; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Ligands; Molecular Structure; Neuropeptide Y; Neurotensin; Oligopeptides; Peptide Fragments; Receptors, Angiotensin; Receptors, Neuropeptide; Receptors, Neurotensin; Structure-Activity Relationship

2016